EXECUTIVE ENGAGEMENTS
OUTREACH
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPETITORS
BRANDS
* Login for a full stack data experience
DATE
JUL 2020
TABLES
123
PAGES
205
EDITION
16
PRICE
USD $5450
HIGHLIGHTS
SELECT PLAYERS
AbbVie, Inc.; AstraZeneca PLC; Boehringer Ingelheim GmbH; Bristol-Myers Squibb Company; Cipla Ltd.; Daiichi Sankyo Co., Ltd.; Emcure Pharmaceuticals Pvt., Ltd.; F. Hoffmann-La Roche AG; Gilead Sciences, Inc.; Hetero Drugs Ltd.; Johnson & Johnson; Merck & Co., Inc.; Teva Pharmaceutical Industries Ltd.; ViiV Healthcare
SEGMENTS
» Medication Class [Multi-Class Combination Drugs, Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Protease Inhibitors (PIs), Fusion Inhibitors (FI), Entry Inhibitors, and HIV Integrase Stand Transfer Inhibitors]
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
TABLE OF CONTENTS
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Global Competitor Market Shares |
HIV Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2028 |
Impact of Covid-19 and a Looming Global Recession |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
4. GLOBAL MARKET PERSPECTIVE |
HIV Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
HIV Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017 |
HIV Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
Multi-Class Combination Drugs (Medication Class) World Market by Region/Country in US$ Million: 2018 to 2025 |
Multi-Class Combination Drugs (Medication Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
Multi-Class Combination Drugs (Medication Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
Nucleoside Reverse Transcriptase Inhibitors (NRTIs) (Medication Class) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025 |
Nucleoside Reverse Transcriptase Inhibitors (NRTIs) (Medication Class) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 |
Nucleoside Reverse Transcriptase Inhibitors (NRTIs) (Medication Class) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) (Medication Class) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025 |
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) (Medication Class) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017 |
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) (Medication Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
Protease Inhibitors (PIs) (Medication Class) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025 |
Protease Inhibitors (PIs) (Medication Class) Market Historic Review by Region/Country in US$ Million: 2009 to 2017 |
Protease Inhibitors (PIs) (Medication Class) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
Fusion Inhibitors (FI) (Medication Class) World Market by Region/Country in US$ Million: 2018 to 2025 |
Fusion Inhibitors (FI) (Medication Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
Fusion Inhibitors (FI) (Medication Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
Entry Inhibitors (Medication Class) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025 |
Entry Inhibitors (Medication Class) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017 |
Entry Inhibitors (Medication Class) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025 |
HIV Integrase Stand Transfer Inhibitors (Medication Class) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025 |
HIV Integrase Stand Transfer Inhibitors (Medication Class) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017 |
HIV Integrase Stand Transfer Inhibitors (Medication Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
III. MARKET ANALYSIS |
GEOGRAPHIC MARKET ANALYSIS |
United States |
Market Facts & Figures |
US HIV Drugs Market Share (in %) by Company: 2019 & 2025 |
United States HIV Drugs Market Estimates and Projections in US$ Million by Medication Class: 2018 to 2025 |
HIV Drugs Market in the United States by Medication Class: A Historic Review in US$ Million for 2009-2017 |
United States HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025 |
Canada |
Canadian HIV Drugs Market Estimates and Forecasts in US$ Million by Medication Class: 2018 to 2025 |
Canadian HIV Drugs Historic Market Review by Medication Class in US$ Million: 2009-2017 |
HIV Drugs Market in Canada: Percentage Share Breakdown of Sales by Medication Class for 2009, 2019, and 2025 |
Japan |
Japanese Market for HIV Drugs: Annual Sales Estimates and Projections in US$ Million by Medication Class for the Period 2018-2025 |
HIV Drugs Market in Japan: Historic Sales Analysis in US$ Million by Medication Class for the Period 2009-2017 |
Japanese HIV Drugs Market Share Analysis by Medication Class: 2009 VS 2019 VS 2025 |
China |
Chinese HIV Drugs Market Growth Prospects in US$ Million by Medication Class for the Period 2018-2025 |
HIV Drugs Historic Market Analysis in China in US$ Million by Medication Class: 2009-2017 |
Chinese HIV Drugs Market by Medication Class: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
Europe |
Market Facts & Figures |
European HIV Drugs Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
European HIV Drugs Market Demand Scenario in US$ Million by Region/Country: 2018-2025 |
HIV Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017 |
European HIV Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
European HIV Drugs Market Estimates and Forecasts in US$ Million by Medication Class: 2018-2025 |
HIV Drugs Market in Europe in US$ Million by Medication Class: A Historic Review for the Period 2009-2017 |
European HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025 |
France |
HIV Drugs Market in France by Medication Class: Estimates and Projections in US$ Million for the Period 2018-2025 |
French HIV Drugs Historic Market Scenario in US$ Million by Medication Class: 2009-2017 |
French HIV Drugs Market Share Analysis by Medication Class: 2009 VS 2019 VS 2025 |
Germany |
HIV Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Medication Class for the Period 2018-2025 |
German HIV Drugs Historic Market Analysis in US$ Million by Medication Class: 2009-2017 |
German HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025 |
Italy |
Italian HIV Drugs Market Growth Prospects in US$ Million by Medication Class for the Period 2018-2025 |
HIV Drugs Historic Market Analysis in Italy in US$ Million by Medication Class: 2009-2017 |
Italian HIV Drugs Market by Medication Class: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
United Kingdom |
United Kingdom Market for HIV Drugs: Annual Sales Estimates and Projections in US$ Million by Medication Class for the Period 2018-2025 |
HIV Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Medication Class for the Period 2009-2017 |
United Kingdom HIV Drugs Market Share Analysis by Medication Class: 2009 VS 2019 VS 2025 |
Spain |
Spanish HIV Drugs Market Estimates and Forecasts in US$ Million by Medication Class: 2018 to 2025 |
Spanish HIV Drugs Historic Market Review by Medication Class in US$ Million: 2009-2017 |
HIV Drugs Market in Spain: Percentage Share Breakdown of Sales by Medication Class for 2009, 2019, and 2025 |
Russia |
Russian HIV Drugs Market Estimates and Projections in US$ Million by Medication Class: 2018 to 2025 |
HIV Drugs Market in Russia by Medication Class: A Historic Review in US$ Million for 2009-2017 |
Russian HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025 |
Rest of Europe |
Rest of Europe HIV Drugs Market Estimates and Forecasts in US$ Million by Medication Class: 2018-2025 |
HIV Drugs Market in Rest of Europe in US$ Million by Medication Class: A Historic Review for the Period 2009-2017 |
Rest of Europe HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025 |
Asia-Pacific |
Asia-Pacific HIV Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
HIV Drugs Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017 |
Asia-Pacific HIV Drugs Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025 |
HIV Drugs Market in Asia-Pacific by Medication Class: Estimates and Projections in US$ Million for the Period 2018-2025 |
Asia-Pacific HIV Drugs Historic Market Scenario in US$ Million by Medication Class: 2009-2017 |
Asia-Pacific HIV Drugs Market Share Analysis by Medication Class: 2009 VS 2019 VS 2025 |
Australia |
HIV Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Medication Class for the Period 2018-2025 |
Australian HIV Drugs Historic Market Analysis in US$ Million by Medication Class: 2009-2017 |
Australian HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025 |
India |
Indian HIV Drugs Market Estimates and Forecasts in US$ Million by Medication Class: 2018 to 2025 |
Indian HIV Drugs Historic Market Review by Medication Class in US$ Million: 2009-2017 |
HIV Drugs Market in India: Percentage Share Breakdown of Sales by Medication Class for 2009, 2019, and 2025 |
South Korea |
HIV Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Medication Class for the Period 2018-2025 |
South Korean HIV Drugs Historic Market Analysis in US$ Million by Medication Class: 2009-2017 |
HIV Drugs Market Share Distribution in South Korea by Medication Class: 2009 VS 2019 VS 2025 |
Rest of Asia-Pacific |
Rest of Asia-Pacific Market for HIV Drugs: Annual Sales Estimates and Projections in US$ Million by Medication Class for the Period 2018-2025 |
HIV Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Medication Class for the Period 2009-2017 |
Rest of Asia-Pacific HIV Drugs Market Share Analysis by Medication Class: 2009 VS 2019 VS 2025 |
Latin America |
Latin American HIV Drugs Market Trends by Region/Country in US$ Million: 2018-2025 |
HIV Drugs Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017 |
Latin American HIV Drugs Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025 |
Latin American HIV Drugs Market Growth Prospects in US$ Million by Medication Class for the Period 2018-2025 |
HIV Drugs Historic Market Analysis in Latin America in US$ Million by Medication Class: 2009-2017 |
Latin American HIV Drugs Market by Medication Class: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
Argentina |
Argentinean HIV Drugs Market Estimates and Forecasts in US$ Million by Medication Class: 2018-2025 |
HIV Drugs Market in Argentina in US$ Million by Medication Class: A Historic Review for the Period 2009-2017 |
Argentinean HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025 |
Brazil |
HIV Drugs Market in Brazil by Medication Class: Estimates and Projections in US$ Million for the Period 2018-2025 |
Brazilian HIV Drugs Historic Market Scenario in US$ Million by Medication Class: 2009-2017 |
Brazilian HIV Drugs Market Share Analysis by Medication Class: 2009 VS 2019 VS 2025 |
Mexico |
HIV Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Medication Class for the Period 2018-2025 |
Mexican HIV Drugs Historic Market Analysis in US$ Million by Medication Class: 2009-2017 |
Mexican HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025 |
Rest of Latin America |
Rest of Latin America HIV Drugs Market Estimates and Projections in US$ Million by Medication Class: 2018 to 2025 |
HIV Drugs Market in Rest of Latin America by Medication Class: A Historic Review in US$ Million for 2009-2017 |
Rest of Latin America HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025 |
Middle East |
The Middle East HIV Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
HIV Drugs Market in the Middle East by Region/Country in US$ Million: 2009-2017 |
The Middle East HIV Drugs Market Share Breakdown by Region/Country: 2009, 2019, and 2025 |
The Middle East HIV Drugs Market Estimates and Forecasts in US$ Million by Medication Class: 2018 to 2025 |
The Middle East HIV Drugs Historic Market by Medication Class in US$ Million: 2009-2017 |
HIV Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Medication Class for 2009, 2019, and 2025 |
Iran |
Iranian Market for HIV Drugs: Annual Sales Estimates and Projections in US$ Million by Medication Class for the Period 2018-2025 |
HIV Drugs Market in Iran: Historic Sales Analysis in US$ Million by Medication Class for the Period 2009-2017 |
Iranian HIV Drugs Market Share Analysis by Medication Class: 2009 VS 2019 VS 2025 |
Israel |
Israeli HIV Drugs Market Estimates and Forecasts in US$ Million by Medication Class: 2018-2025 |
HIV Drugs Market in Israel in US$ Million by Medication Class: A Historic Review for the Period 2009-2017 |
Israeli HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025 |
Saudi Arabia |
Saudi Arabian HIV Drugs Market Growth Prospects in US$ Million by Medication Class for the Period 2018-2025 |
HIV Drugs Historic Market Analysis in Saudi Arabia in US$ Million by Medication Class: 2009-2017 |
Saudi Arabian HIV Drugs Market by Medication Class: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
United Arab Emirates |
HIV Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Medication Class for the Period 2018-2025 |
United Arab Emirates HIV Drugs Historic Market Analysis in US$ Million by Medication Class: 2009-2017 |
HIV Drugs Market Share Distribution in United Arab Emirates by Medication Class: 2009 VS 2019 VS 2025 |
Rest of Middle East |
HIV Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Medication Class for the Period 2018-2025 |
Rest of Middle East HIV Drugs Historic Market Analysis in US$ Million by Medication Class: 2009-2017 |
Rest of Middle East HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025 |
Africa |
African HIV Drugs Market Estimates and Projections in US$ Million by Medication Class: 2018 to 2025 |
HIV Drugs Market in Africa by Medication Class: A Historic Review in US$ Million for 2009-2017 |
African HIV Drugs Market Share Breakdown by Medication Class: 2009 VS 2019 VS 2025 |
IV. COMPETITION |
Total Companies Profiled: 52 |